684 related articles for article (PubMed ID: 30257667)
21. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi).
Chihana ML; Huerga H; Van Cutsem G; Ellman T; Goemaere E; Wanjala S; Masiku C; Szumilin E; Etard JF; Maman D; Davies MA
Glob Health Action; 2019; 12(1):1679472. PubMed ID: 31679482
[No Abstract] [Full Text] [Related]
22. The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis.
Bastos ML; Melnychuk L; Campbell JR; Oxlade O; Menzies D
PLoS Med; 2021 Sep; 18(9):e1003703. PubMed ID: 34492003
[TBL] [Abstract][Full Text] [Related]
23. Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004-2012.
Pathmanathan I; Dokubo EK; Shiraishi RW; Agolory SG; Auld AF; Onotu D; Odafe S; Dalhatu I; Abiri O; Debem HC; Bashorun A; Ellerbrock T
PLoS One; 2017; 12(3):e0173309. PubMed ID: 28282390
[TBL] [Abstract][Full Text] [Related]
24. Provision of antiretroviral therapy for HIV-positive TB patients--19 countries, sub-Saharan Africa, 2009-2013.
Dokubo EK; Baddeley A; Pathmanathan I; Coggin W; Firth J; Getahun H; Kaplan J; Date A
MMWR Morb Mortal Wkly Rep; 2014 Nov; 63(47):1104-7. PubMed ID: 25426652
[TBL] [Abstract][Full Text] [Related]
25. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
Dutta A; Barker C; Kallarakal A
PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
[TBL] [Abstract][Full Text] [Related]
26. Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries.
Harries AD; Schwoebel V; Monedero-Recuero I; Aung TK; Chadha S; Chiang CY; Conradie F; Dongo JP; Heldal E; Jensen P; Nyengele JPK; Koura KG; Kumar AMV; Lin Y; Mlilo N; Nakanwagi-Mukwaya A; Ncube RT; Nyinoburyo R; Oo NL; Patel LN; Piubello A; Rusen ID; Sanda T; Satyanarayana S; Syed I; Thu AS; Tonsing J; Trébucq A; Zamora V; Zishiri C; Hinderaker SG; Aït-Khaled N; Roggi A; Caminero Luna J; Graham SM; Dlodlo RA; Fujiwara PI
Int J Tuberc Lung Dis; 2019 Feb; 23(2):241-251. PubMed ID: 30808459
[TBL] [Abstract][Full Text] [Related]
27. Mortality trends in the era of antiretroviral therapy: evidence from the Network for Analysing Longitudinal Population based HIV/AIDS data on Africa (ALPHA).
Reniers G; Slaymaker E; Nakiyingi-Miiro J; Nyamukapa C; Crampin AC; Herbst K; Urassa M; Otieno F; Gregson S; Sewe M; Michael D; Lutalo T; Hosegood V; Kasamba I; Price A; Nabukalu D; Mclean E; Zaba B;
AIDS; 2014 Nov; 28 Suppl 4(4):S533-42. PubMed ID: 25406756
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of the benefit of different complementary exams in the search for a TB diagnosis algorithm for HIV patients put on ART in Niamey, Niger].
Ouedraogo E; Lurton G; Mohamadou S; Dillé I; Diallo I; Mamadou S; Adehossi E; Hanki Y; Tchousso O; Arzika M; Gazeré O; Amadou F; Illo N; Abdourahmane Y; Idé M; Alhousseini Z; Lamontagne F; Deze C; D'Ortenzio E; Diallo S
Bull Soc Pathol Exot; 2016 Dec; 109(5):368-375. PubMed ID: 27848101
[TBL] [Abstract][Full Text] [Related]
29. Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis.
Yanes-Lane M; Ortiz-Brizuela E; Campbell JR; Benedetti A; Churchyard G; Oxlade O; Menzies D
PLoS Med; 2021 Sep; 18(9):e1003738. PubMed ID: 34520459
[TBL] [Abstract][Full Text] [Related]
30. Impact of the antiretroviral treatment program on the burden of hospitalization for culture-confirmed tuberculosis in South African children: a time-series analysis.
Dangor Z; Izu A; Hillier K; Solomon F; Beylis N; Moore DP; Nunes MC; Madhi SA
Pediatr Infect Dis J; 2013 Sep; 32(9):972-7. PubMed ID: 23503163
[TBL] [Abstract][Full Text] [Related]
31. Naomi: a new modelling tool for estimating HIV epidemic indicators at the district level in sub-Saharan Africa.
Eaton JW; Dwyer-Lindgren L; Gutreuter S; O'Driscoll M; Stevens O; Bajaj S; Ashton R; Hill A; Russell E; Esra R; Dolan N; Anifowoshe YO; Woodbridge M; Fellows I; Glaubius R; Haeuser E; Okonek T; Stover J; Thomas ML; Wakefield J; Wolock TM; Berry J; Sabala T; Heard N; Delgado S; Jahn A; Kalua T; Chimpandule T; Auld A; Kim E; Payne D; Johnson LF; FitzJohn RG; Wanyeki I; Mahy MI; Shiraishi RW
J Int AIDS Soc; 2021 Sep; 24 Suppl 5(Suppl 5):e25788. PubMed ID: 34546657
[TBL] [Abstract][Full Text] [Related]
32. Leveraging differentiated HIV service delivery to expand tuberculosis preventive treatment: a call to action.
Rabkin M; Howard AA; Ehrenkranz P; Fernandez LG; Preko P; Singh V; Tomlinson HL; El-Sadr WM
Int J Tuberc Lung Dis; 2020 Feb; 24(2):165-169. PubMed ID: 32127099
[TBL] [Abstract][Full Text] [Related]
33. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.
Harries AD; Zachariah R; Lawn SD
Int J Tuberc Lung Dis; 2009 Jan; 13(1):6-16. PubMed ID: 19105873
[TBL] [Abstract][Full Text] [Related]
34. Trend of tuberculosis case notifications and their determinants in Africa and South-East Asia during 2000-2018: a longitudinal analysis of national data from 58 countries.
Boah M; Adampah T; Jin B; Wang W; Wang K
Infect Dis (Lond); 2020 Aug; 52(8):538-546. PubMed ID: 32431192
[No Abstract] [Full Text] [Related]
35. Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community.
Middelkoop K; Bekker LG; Myer L; Johnson LF; Kloos M; Morrow C; Wood R
J Acquir Immune Defic Syndr; 2011 Mar; 56(3):263-9. PubMed ID: 21317585
[TBL] [Abstract][Full Text] [Related]
36. Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in India.
Gupte AN; Kadam D; Sangle S; Rewari BB; Salvi S; Chavan A; Nimkar S; Golub J; Gupte N; Gupta A; Marbaniang I; Mave V
BMC Infect Dis; 2019 Oct; 19(1):914. PubMed ID: 31664933
[TBL] [Abstract][Full Text] [Related]
37. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.
Rajasingham R; Smith RM; Park BJ; Jarvis JN; Govender NP; Chiller TM; Denning DW; Loyse A; Boulware DR
Lancet Infect Dis; 2017 Aug; 17(8):873-881. PubMed ID: 28483415
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis.
Chindelevitch L; Menzies NA; Pretorius C; Stover J; Salomon JA; Cohen T
J R Soc Interface; 2015 May; 12(106):. PubMed ID: 25878131
[TBL] [Abstract][Full Text] [Related]
39. Managing household income and antiretroviral therapy adherence among people living with HIV in a low-income setting: a qualitative data from the HPTN 071 (PopART) trial in South Africa.
Mcinziba A; Bock P; Hoddinott G; Seeley J; Bond V; Fidler S; Viljoen L
AIDS Res Ther; 2023 Aug; 20(1):54. PubMed ID: 37542278
[TBL] [Abstract][Full Text] [Related]
40. Post-treatment effect of isoniazid preventive therapy on tuberculosis incidence in HIV-infected individuals on antiretroviral therapy.
Sumner T; Houben RM; Rangaka MX; Maartens G; Boulle A; Wilkinson RJ; White RG
AIDS; 2016 May; 30(8):1279-86. PubMed ID: 26950316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
